Using the Energy Gap to Prevent Weight Regain
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Denver |
| State: |
|
Colorado |
| Zip Code: |
|
80262 |
| Conditions: |
|
Obesity |
| Purpose: |
|
The major challenge in obesity treatment is not producing weight loss but in preventing that
weight from being regained. There are many different methods to lose weight, but there are
no recommendations for how you can best achieve long-term weight loss maintenance. Despite
the method used to reduce one's body weight, very few of these individuals are able to keep
their weight off permanently. This project aims to identify how much activity is necessary
to prevent weight regain after weight loss.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. All ethnic groups and both genders
2. Age: Lower age limit: 19 years; Upper age limit: 45 years
3. Body-mass Index: Lower BMI limit: 30 kg/m2; Upper BMI limit: 40 kg/m2 and weight
stable within +/- 5 pounds in the last 6 months, and currently at maximum non
pregnant body weight (+/- 5%)
4. A negative treadmill stress test or subsequent follow up cardiac testing for cardiac
ischemia.
Exclusion Criteria:
1. History of cardiovascular disease, including coronary artery disease, congestive
heart failure, & unstable angina, or uncontrolled hypertension ( > 140/90 mm Hg)
2. Currently smoking or stopped smoking in the last 12 months
3. Medications affecting weight, energy intake, or energy expenditure in the last 6
months
4. Use of oral steroids within the last 12 months
5. History of stroke or seizures, thyroid disease, type 1 or 2 diabetes, Cushings
syndrome, cerebrovascular, renal disease, hepatic disease, arrhythmias
6. Cancer requiring treatment in the past 5 years, with the exception of skin cancers
other than melanoma
7. Infectious diseases: Self-reported HIV positivity or Active tuberculosis
8. Weight loss or weight gain of > 5% in past 6 months for any reason except post-partum
weight loss
9. Likely to move away in next 1.5 years
10. Inability to adhere to the program such as inability to increase walking
11. Currently pregnant, lactating or less than 6 months post-partum
12. Major psychiatric disorder: Exclusions related to medications -Antipsychotic agents
(these include, but are not limited to: Haldol, Loxitane, Mellaril, Navane, Prolixin,
Stelazine, Thorazine, and Trilafon)
13. Current depression by history or Beck Depression Inventory (BDI)
14. Currently being treated for psychological condition
|
| NCT ID: |
|
NCT00429650 |
| Primary Contact: |
|
Principal Investigator
Holly R. Wyatt, MD
University of Colorado at Denver Health Sciences Center
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Denver, Colorado 80262
United States
Emily Schwall
Email: emily.schwall@uchsc.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|